Natco Pharma Ltd (NSE:NATCOPHARM)
₹ 1196.15 -4.5 (-0.37%) Market Cap: 214.17 Bil Enterprise Value: 199.39 Bil PE Ratio: 15.54 PB Ratio: 3.68 GF Score: 82/100

Q1 2022 Natco Pharma Ltd Earnings Call Transcript

Aug 12, 2021 / 12:30PM GMT
Release Date Price: ₹1041.45 (+3.06%)
Operator

Ladies and gentlemen, good day, and welcome to NATCO Pharma Q1 FY 2022 Earnings Conference Call hosted by Investec Capital Services Private Limited. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Anshuman Gupta. Thank you and over to you, sir.

Anshuman M. Gupta
Investec Bank plc, Research Division - Research Analyst

Thank you, moderator, and good evening, everyone. On behalf of Investec Capital Services, I welcome you all for NATCO Pharma's 1Q FY '22 Earnings Call. Today, we have the senior management represented by Mr. Rajeev. He's the Vice Chairman and CEO. And we also have Mr. Rajesh, the Vice President of Investor Relations and Corporate Communications. Over to you, Rajesh sir. Thank you.

Rajesh Chebiyam
NATCO Pharma Limited - VP of Acquisitions, Institutional Investor Management & Corporate Communications

Yes. Thank you, Anshuman. Again, good evening, everyone, and welcome to NATCO's conference call discussing our earnings results for the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot